Canid secures $10M in a Series A funding to transform vaccine management with its AI-driven platform. The funding will eliminate the administrative burden for pediatricians.
Canid secures $10M in a Series A funding to transform vaccine management with its AI-driven platform. The funding will eliminate the administrative burden for pediatricians.
06/03/25, 6:39 PM
Location
new yorkMoney raised
$10 million
Industry
medical
artificial intelligence
biotechnology
health care
information technology
Round Type
series a
Canid has successfully raised $10 million in a Series A funding to enhance its AI-driven vaccine management platform. This funding aims to streamline processes for pediatricians, reducing their administrative workload significantly. The investment will also help in further developing and deploying the technology. Canid’s innovative approach is set to revolutionize vaccine management.
Company Info
Location
new york, new york, united states
Additional Info
Canid is revolutionizing pediatric vaccine management by turning the complex and expensive process of giving a vaccine into a simple scan-and-go workflow. Canid’s platform integrates directly with electronic health record systems and uses AI, software and economies of scale to drastically reduce the time and money pediatricians must spend on this crucial but burdensome process.